ResearcherFirst Affiliated Hospital of Zhengzhou UniversityNo recent work listed

Qi Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0037-1042; OpenAlex author ID A5100319741. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers

Papers 3

Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. Co-author DOI 10.1016/j.ymthe.2022.11.004 ↗
CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling. Co-author DOI 10.1186/s12885-023-10615-w ↗
High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41598-022-22355-1 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuan Nie · 1 shared paper, 2023 · strength 0.26
- Paper CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling. DOI 10.1186/s12885-023-10615-w ↗
Xuan Zhu · 1 shared paper, 2023 · strength 0.26
- Paper CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling. DOI 10.1186/s12885-023-10615-w ↗
Yun Wang · 1 shared paper, 2022 · strength 0.16
- Paper High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma. DOI 10.1038/s41598-022-22355-1 ↗
Wenzhi Guo · 1 shared paper, 2022 · strength 0.16
- Paper High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma. DOI 10.1038/s41598-022-22355-1 ↗
Yong Wang · 1 shared paper, 2022 · strength 0.16
- Paper High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma. DOI 10.1038/s41598-022-22355-1 ↗
Shuijun Zhang · 1 shared paper, 2022 · strength 0.16
- Paper High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma. DOI 10.1038/s41598-022-22355-1 ↗
Yin-Hao Shi · 1 shared paper, 2023 · strength 0.16
- Paper Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. DOI 10.1016/j.ymthe.2022.11.004 ↗
Ying‐Qin Zhu · 1 shared paper, 2023 · strength 0.16
- Paper Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. DOI 10.1016/j.ymthe.2022.11.004 ↗
Zhide Liu · 1 shared paper, 2023 · strength 0.16
- Paper Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. DOI 10.1016/j.ymthe.2022.11.004 ↗
Jie‐Qin Wang · 1 shared paper, 2023 · strength 0.16
- Paper Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. DOI 10.1016/j.ymthe.2022.11.004 ↗
Chen‐Song Huang · 1 shared paper, 2023 · strength 0.16
- Paper Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. DOI 10.1016/j.ymthe.2022.11.004 ↗
Xiaoyu Yin · 1 shared paper, 2023 · strength 0.16
- Paper Imatinib facilitates gemcitabine sensitivity by targeting epigenetically activated PDGFC signaling in pancreatic cancer. DOI 10.1016/j.ymthe.2022.11.004 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.